Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK S HUMAYUN

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1548322381
CMS profile
252052
Location
LOS ANGELES, CA

General Payments · PY2018–2024

$49,696.76

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,554.28

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alcon Research LLC $7,604.04 5
Alcon Laboratories Inc $1,439.38 4
Bausch & Lomb Americas Inc. $297.79 3
Alimera Sciences, Inc. $127.07 1
Regeneron Pharmaceuticals, Inc. $86.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $5,597.95 10
PY2019 $10,611.15 10
PY2020 $5,126.94 4
PY2021 $5,132.93 3
PY2022 $8,166.83 15
PY2023 $5,506.68 7
PY2024 $9,554.28 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alcon Research LLC $658.00 02/14/2024 Travel and Lodging Undisputed 01/23/2026 1089699973 CMS
Alcon Research LLC $5,000.00 04/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1089699977 CMS
Alcon Research LLC $71.67 10/04/2024 Food and Beverage Undisputed 01/23/2026 1082190642 CMS
Alcon Research LLC $1,835.96 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1089699975 CMS
Alcon Research LLC $38.41 10/17/2024 Food and Beverage Undisputed 01/23/2026 1082190640 CMS
Alcon Vision LLC $145.71 06/20/2024 Food and Beverage Undisputed 01/23/2026 1110636749 CMS
Alcon Vision LLC $278.51 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1110525065 CMS
Alcon Vision LLC $524.76 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1110525067 CMS
Alcon Vision LLC $490.40 10/04/2024 Food and Beverage Undisputed 01/23/2026 1110636751 CMS
Alimera Sciences, Inc. $127.07 08/28/2024 Food and Beverage Undisputed 01/23/2026 1092839650 CMS
Bausch & Lomb Americas Inc. $130.93 03/12/2024 Food and Beverage Undisputed 01/23/2026 1140403184 CMS
Bausch & Lomb Americas Inc. $49.65 06/06/2024 Food and Beverage Undisputed 01/23/2026 1140403186 CMS
Bausch & Lomb Americas Inc. $117.21 08/06/2024 Food and Beverage Undisputed 01/23/2026 1140403188 CMS
Regeneron Pharmaceuticals, Inc. $86.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 1114400299 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.